Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients

OBJECTIVES: Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is the only currently available curative treatment for sickle cell disease (SCD). Here, we comprehensively evaluated the reconstitution of T‐ and B‐cell compartments in 29 SCD patients treated with allo‐HSCT and how it corre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarduli‐Maciel, Luciana Ribeiro, de Azevedo, Júlia Teixeira Cottas, Clave, Emmanuel, Costa, Thalita Cristina de Mello, Arruda, Lucas Coelho Marlière, Fournier, Isabelle, Palma, Patrícia Vianna Bonini, Lima, Keli Cristina, Elias, Juliana Bernardes, Stracieri, Ana Beatriz PL, Pieroni, Fabiano, Cunha, Renato, Darrigo‐Júnior, Luiz Guilherme, Grecco, Carlos Eduardo Settani, Covas, Dimas Tadeu, Silva‐Pinto, Ana Cristina, De Santis, Gil Cunha, Simões, Belinda Pinto, Oliveira, Maria Carolina, Toubert, Antoine, Malmegrim, Kelen Cristina Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035210/
https://www.ncbi.nlm.nih.gov/pubmed/35474905
http://dx.doi.org/10.1002/cti2.1389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035210/
https://www.ncbi.nlm.nih.gov/pubmed/35474905
http://dx.doi.org/10.1002/cti2.1389

Ejemplares similares